Folefac Aminkeng

1.8k total citations
26 papers, 689 citations indexed

About

Folefac Aminkeng is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Folefac Aminkeng has authored 26 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Genetics and 6 papers in Immunology. Recurrent topics in Folefac Aminkeng's work include Immune Cell Function and Interaction (5 papers), Diabetes and associated disorders (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Folefac Aminkeng is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Diabetes and associated disorders (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Folefac Aminkeng collaborates with scholars based in Singapore, Canada and Belgium. Folefac Aminkeng's co-authors include Michael R. Hayden, Bruce Carleton, Colin J.D. Ross, Amit P. Bhavsar, Shahrad R. Rassekh, Anne Smith, Ursula Amstutz, Daniel Bernstein, Karen A. Gelmon and Shubhayan Sanatani and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Cancer.

In The Last Decade

Folefac Aminkeng

26 papers receiving 683 citations

Peers

Folefac Aminkeng

ONCOL

GENET

CCM

CMN

Wuning Mo China

Samuel Martín‐Vílchez Spain

Bernd Hartmann Austria

Thomas Pusl Germany

Gavin Lucas Spain

Christine Veyrat‐Follet France

Gitte Hoffmann Bruun Denmark

Brian Estevez United States

Sarah Donald United Kingdom

Kiang-Teck J Yeo United States

Wuning Mo China

Folefac Aminkeng

227 ×1.1

146 ×0.8

ONCOL

48 ×0.4

GENET

80 ×0.6

CCM

40 ×0.4

CMN

Citations per year, relative to Folefac Aminkeng Folefac Aminkeng (= 1×) peers Wuning Mo

Countries citing papers authored by Folefac Aminkeng

Since Specialization

Citations

This map shows the geographic impact of Folefac Aminkeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Folefac Aminkeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Folefac Aminkeng more than expected).

Fields of papers citing papers by Folefac Aminkeng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Folefac Aminkeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Folefac Aminkeng. The network helps show where Folefac Aminkeng may publish in the future.

Co-authorship network of co-authors of Folefac Aminkeng

This figure shows the co-authorship network connecting the top 25 collaborators of Folefac Aminkeng. A scholar is included among the top collaborators of Folefac Aminkeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Folefac Aminkeng. Folefac Aminkeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Yiqing, Joseph J. Zhao, Yu Yang Soon, et al.. (2023). Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer. Cancers. 15(10). 2733–2733. 12 indexed citations

Oni‐Orisan, Akinyemi, Sony Tuteja, D. Max Smith, et al.. (2023). An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare Providers. Clinical Pharmacology & Therapeutics. 114(2). 275–287. 6 indexed citations

Tay, Sen Hee, Yee Liang Thian, Balamurugan Vellayappan, et al.. (2022). Cytokine Release Syndrome in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Case Series of 25 Patients and Review of the Literature. Frontiers in Immunology. 13. 807050–807050. 70 indexed citations

Ooi, Jolene, Sarah R. Langley, Xiaohong Xu, et al.. (2019). Unbiased Profiling of Isogenic Huntington Disease hPSC-Derived CNS and Peripheral Cells Reveals Strong Cell-Type Specificity of CAG Length Effects. Cell Reports. 26(9). 2494–2508.e7. 55 indexed citations

Chan, Sze Ling, Folefac Aminkeng, Cynthia Bin Eng Chee, et al.. (2017). Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients. PLoS ONE. 12(10). e0186200–e0186200. 39 indexed citations

Medeiros-Domingo, Mara, Folefac Aminkeng, Rodolfo Rivas-Ruíz, et al.. (2017). Pharmacogenomic Prediction of Cisplatin-Induced Nephrotoxicity in Patients Treated for Childhood Cancer. Journal of Pharmacological and Toxicological Methods. 88. 173–174. 1 indexed citations

Kowalec, Kaarina, Galen E.B. Wright, Britt I. Drögemöller, et al.. (2016). Genome-wide scan identifies association between an interferon regulatory factor-related variant and interferon-beta induced liver injury in multiple sclerosis patients. Multiple Sclerosis Journal. 22(3). 834–836. 1 indexed citations

Aminkeng, Folefac, Colin J.D. Ross, Shahrad R. Rassekh, et al.. (2016). Recommendations for genetic testing to reduce the incidence of anthracycline‐induced cardiotoxicity. British Journal of Clinical Pharmacology. 82(3). 683–695. 167 indexed citations

Sobngwi, Eugène, et al.. (2015). Contribution of the TCF7L2 rs7903146 (C/T) gene polymorphism to the susceptibility to type 2 diabetes mellitus in Cameroon. Journal of Diabetes & Metabolic Disorders. 14(1). 26–26. 22 indexed citations

10.

Sobngwi, Eugène, et al.. (2015). Association between the rs12255372 variant of the TCF7L2 gene and obesity in a Cameroonian population. BMC Research Notes. 8(1). 717–717. 11 indexed citations

11.

Brunham, Liam R., Sze Ling Chan, Folefac Aminkeng, et al.. (2014). Pharmacogenomic diversity in Singaporean populations and Europeans. The Pharmacogenomics Journal. 14(6). 555–563. 13 indexed citations

12.

Sobngwi, Eugène, et al.. (2014). P17 No Association between Pro12Ala polymorphism in Peroxisome Proliferator Activated Receptor Gamma 2 gene and type 2 diabetes in a Cameroonian population. Diabetes Research and Clinical Practice. 103. S37–S38. 1 indexed citations

13.

Aminkeng, Folefac, Colin J.D. Ross, Shahrad R. Rassekh, et al.. (2013). Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent. The Pharmacogenomics Journal. 14(2). 160–170. 25 indexed citations

14.

Gorus, Frans, Ilse Weets, Bart Van Der Auwera, et al.. (2013). Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: Relation to autoantibody status and comparison with Belgian patients. Diabetes Research and Clinical Practice. 103(1). 97–105. 15 indexed citations

15.

Aminkeng, Folefac, Ilse Weets, Bobby P. C. Koeleman, et al.. (2010). Association of IL-2RA/CD25 with type 1 diabetes in the Belgian population. Human Immunology. 71(12). 1233–1237. 7 indexed citations

16.

Aminkeng, Folefac, Ilse Weets, Erik Quartier, et al.. (2009). IFIH1 gene polymorphisms in type 1 diabetes: Genetic association analysis and genotype–phenotype correlation in the Belgian population. Human Immunology. 70(9). 706–710. 16 indexed citations

17.

Ramos‐Lopez, Elizabeth, Folefac Aminkeng, Christopher P. Wild, et al.. (2009). Association of KIR2DL2 polymorphism rs2756923 with type 1 diabetes and preliminary evidence for lack of inhibition through HLA‐C1 ligand binding. Tissue Antigens. 73(6). 599–603. 13 indexed citations

18.

Aminkeng, Folefac, Bobby P. C. Koeleman, Erik Quartier, et al.. (2007). TNFa microsatellite polymorphism modulates the risk of type 1 diabetes in the Belgian population, independent of HLA-DQ. Human Immunology. 68(8). 690–697. 8 indexed citations

19.

Koeleman, Bobby P. C., Erik Quartier, Folefac Aminkeng, et al.. (2006). MICA is Associated with Type 1 Diabetes in the Belgian Population, Independent of HLA-DQ. Human Immunology. 67(1-2). 94–101. 15 indexed citations

20.

Ramos‐Lopez, Elizabeth, Folefac Aminkeng, J. Herwig, et al.. (2006). Neither an intronic CA repeat within the CD48 gene nor the HERV‐K18 polymorphisms are associated with type 1 diabetes. Tissue Antigens. 68(2). 147–152. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact